ALASTINTM Skincare, Inc. Expands Aesthetic Portfolio with Launch of Innovative Restore & Renew Anti-Aging Line Restore & Renew Line Includes Four New Products: Restorative Skin ComplexTM, Restorative Eye Treatment, Renewal Retinol .5 and Ultra Nourishing Moisturizer
CARLSBAD, CA – May 10th, 2016 – ALASTINTM Skincare, Inc., a specialty skin care company dedicated to developing and marketing innovative, clinically-tested skin care products, announced today the launch of the newest addition to their cosmeceutical skin care portfolio, the Restore & Renew Anti-Aging line. The Restore & Renew line utilizes the latest advancements in skin care science to combat major skin issues related to aging and environmental stress. The line provides comprehensive daily skin care with products featuring ALASTINTM’s patent-pending TriHex TechnologyTM, which works to stimulate, strengthen and support the skin.
The Restore & Renew line consists of four products, including the flagship product Restorative Skin ComplexTM, which is formulated to help enhance production of collagen and elastin, recycle the extracellular matrix and volumize the skin for a more youthful appearance. The Restorative Eye Treatment helps lift the upper eyelid, reduce appearance of crow’s feet and target puffiness and undereye dark circles. Renewal Retinol .5 is designed to diminish the appearance of fine lines and wrinkles, improve skin tone and texture and protect against dehydration. Ultra Nourishing Moisturizer is formulated to enhance production of collagen and elastin, restore the skin’s barrier function and improve hydration and moisture balance.
In histological studies, ALASTINTM products with TriHex Technology™ have been shown to enhance extracellular matrix recycling – the clearing and optimizing of the skin matrix necessary for natural skin regeneration – while helping to stimulate new collagen and elastin deposition. In a recent survey of Restorative Skin Complex™ users, 92 percent shared that their face felt firmer and their lines and wrinkles were less visible, while 100 percent of the users were satisfied with the results and would recommend ALASTINTM products to others.*
“Levels of elastin and collagen begin to diminish as we age, making our skin appear older,” said Diane S. Goostree, President and CEO of ALASTIN™ Skincare. “With the Restore & Renew line, we’ve gone beyond traditional anti-aging regimens to create products that help to reawaken the skin’s natural ability to rejuvenate itself, leading to a more youthful appearance and healthier skin while enhancing skin elasticity and volume.”
TriHex Technology™ and other key ingredients in the Restore & Renew line are designed to improve skin volume and lift, fine lines and wrinkles, thin skin, pigmentation concerns, tone and texture, thus improving overall skin health. The ALASTINTM Restore & Renew line is available for purchase through select dermatologists, plastic and cosmetic surgeons. For more information, please visit our website at www.alastin.com
*Reference: Data on file; ALASTINTM Skincare About ALASTIN™ Skincare, Inc. ALASTIN™ Skincare is dedicated to developing innovative, clinically-tested skin care products that correct, protect and maintain healthy skin for a lifetime. Our unparalleled Procedure Enhancement and Restore & Renew products are formulated with a proprietary combination of key peptides and other synergistic ingredients using the latest technology and are clinically tested to demonstrate safety and their ability to help reawaken the skin’s youthful regenerating processes.
To schedule your consultation with Dr. West, email us at Info@WestSkinLaser.com or call 301-986-9378 (WEST) today!
About Dr. West
Dr. Tina B. West, founder of the West Institute, has served as a consultant and injectable trainer for Allergan and Galderma, training other physicians in advanced treatment techniques using Restylane, Perlane, Scupltra and Dysport as well as Botox.
Dr. West is a board-certified Dermatologist and leading expert in cosmetic dermatology, laser surgery and body contouring procedures.
Dr. West participated in the original phase III FDA clinical trials for the approval of Botox.